DRTTF vs DRMAW: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

Both stocks have similar AI ratings. Review detailed metrics below.

DRTTF
DIRTT ENVIRONMENTAL SOLUTIONS LTD
STRONG SELL
92%
Confidence
VS
DRMAW
Dermata Therapeutics, Inc.
STRONG SELL
92%
Confidence

DRTTF vs DRMAW Fundamental Comparison

Metric DRTTF DRMAW
Revenue $168.9M $161,357.0
Net Income $-14.4M $-5.7M
Net Margin -8.6% -3,530.5%
ROE -50.6% -143.9%
ROA -14.1% -112.3%
Current Ratio 1.10x 7.66x
Debt/Equity 0.82x 0.00x
EPS $-0.08 $-6.64

Green = Better metric | Red = Weaker metric

View Full DRTTF Analysis →
View Full DRMAW Analysis →

You Might Also Compare

DRTTF vs AAPL DRMAW vs MSFT DRTTF vs GOOGL DRMAW vs AMZN

DRTTF vs DRMAW: Frequently Asked Questions

Is DRTTF or DRMAW a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), both stocks have similar ratings. DRTTF is rated STRONG SELL (92% confidence) while DRMAW is rated STRONG SELL (92% confidence). This is not investment advice.

How does DRTTF compare to DRMAW fundamentally?

DIRTT ENVIRONMENTAL SOLUTIONS LTD has ROE of -50.6% vs Dermata Therapeutics, Inc.'s -143.9%. Net margins are -8.6% vs -3,530.5% respectively.

Which stock pays higher dividends, DRTTF or DRMAW?

DRTTF has a dividend yield of N/A or no dividend while DRMAW has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in DRTTF or DRMAW for long term?

For long-term investing, consider that DRTTF has STRONG SELL rating with 92% confidence, while DRMAW has STRONG SELL rating with 92% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about DRTTF vs DRMAW?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For DRTTF vs DRMAW, both AIs rate them similarly based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.